Data Modeling

Mathematical and Computational Data Modeling
0
Citations
4.5k
Views
29
Articles
Your new experience awaits. Try the new design now and help us make it even better
Switch to the new experience
RESEARCH ARTICLE   (Open Access)

Brain-Tech Fusion: A Survey-Based Assessment of Depression Severity and the Case for Integrating Neuromodulatory Interventions in Treatment-Resistant Care

Abstract 1. Introduction 2. Methods 3. Results 4. Discussion 5. Limitations of the Study 6. Conclusion Author Contribution Acknowledgement Competing Financial Interests References

Kamruzzaman Mithu 1*, Khandahar A. Mamun 1

+ Author Affiliations

Data Modeling 1 (1) 1-9 https://doi.org/10.25163/data.1110844

Submitted: 16 April 2020 Revised: 03 June 2020  Accepted: 12 June 2020  Published: 14 June 2020 


Abstract

Depression remains one of the more stubborn contributors to global disease burden, and its severity — not just its presence — often determines whether standard care is enough. This study set out, somewhat modestly, to estimate the distribution of depressive symptom severity within a community sample and to explore whether a subset of respondents showed signs consistent with progression toward schizophrenia-spectrum presentations. A 29-item screening survey was administered to approximately 300 respondents, with a separate online survey examining depression-to-psychosis transition risk. Severity scores were used to classify respondents into normal, moderate, and severe categories. Of the sample, 6.3% met criteria for severe depression, a subgroup at elevated risk for both suicidality and psychotic progression; a related subset also showed patterns consistent with this progression. These findings, while descriptive rather than diagnostic, echo established evidence that treatment-resistant depression often requires escalating intervention beyond first-line medication, and they lend renewed relevance to brain-based options — electroconvulsive therapy, transcranial magnetic stimulation, and, in rare cases, neurosurgical approaches — each carrying its own balance of efficacy and risk. Taken together, the results suggest that even a modest screening effort can surface a clinically meaningful subgroup, one that stands to benefit from earlier identification and a clearer pathway toward the fuller spectrum of available treatments.

Keywords: Depression severity; Treatment-resistant depression; Neuromodulation; Electroconvulsive therapy; Schizophrenia-spectrum progression

References

Ferrari, A. J., Somerville, A. J., Baxter, A. J., et al. (2013). Global variation in the prevalence and incidence of major depressive disorder: A systematic review of the epidemiological literature. Psychological Medicine, 43(3), 471–481. https://doi.org/10.1017/S0033291712001511

Kessler, R. C., Chiu, W. T., Demler, O., Merikangas, K. R., & Walters, E. E. (2005). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62(6), 617–627. https://doi.org/10.1001/archpsyc.62.6.617

World Health Organization. (2008). The global burden of disease: 2004 update. World Health Organization.

Murray, C. J. L., Vos, T., Lozano, R., et al. (2012). Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: A systematic analysis for the Global Burden of Disease Study 2010. The Lancet, 380(9859), 2197–2223. https://doi.org/10.1016/S0140-6736(12)61689-4

Rush, A. J., Trivedi, M. H., Wisniewski, S. R., et al. (2006). Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report. American Journal of Psychiatry, 163(11), 1905–1917. https://doi.org/10.1176/ajp.2006.163.11.1905

Kho, K. H., van Vreeswijk, M. F., Simpson, S., & Zwinderman, A. H. (2003). A meta-analysis of electroconvulsive therapy efficacy in depression. Journal of ECT, 19(3), 139–147. https://doi.org/10.1097/00124509-200309000-00005

Prudic, J., Sackeim, H. A., & Devanand, D. P. (1990). Medication resistance and clinical response to electroconvulsive therapy. Psychiatry Research, 31(3), 287–296. https://doi.org/10.1016/0165-1781(90)90098-P

Devanand, D. P., Sackeim, H. A., & Prudic, J. (1991). Electroconvulsive therapy in the treatment-resistant patient. Psychiatric Clinics of North America, 14(4), 905–923.

Sackeim, H. A., Prudic, J., Fuller, R., Keilp, J., Lavori, P. W., & Olfson, M. (2007). The cognitive effects of electroconvulsive therapy in community settings. Neuropsychopharmacology, 32(1), 244–254. https://doi.org/10.1038/sj.npp.1301180

Sackeim, H. A. (2000). Memory and ECT: From polarization to reconciliation. Journal of ECT, 16(2), 87–96. https://doi.org/10.1097/00124509-200006000-00001

Donahue, A. B. (2000). Electroconvulsive therapy and memory loss: A personal journey. Journal of ECT, 16(2), 133–143. https://doi.org/10.1097/00124509-200006000-00005

Zervas, I. M., Calev, A., Jandorf, L., et al. (1993). Age-dependent effects of electroconvulsive therapy on memory. Convulsive Therapy, 9(1), 39–42.

Tokutsu, Y., Umene-Nakano, W., Shinkai, T., et al. (2013). Follow-up study on electroconvulsive therapy in treatment-resistant depressed patients after remission: A chart review. Clinical Psychopharmacology and Neuroscience, 11(1), 34–38. https://doi.org/10.9758/cpn.2013.11.1.34

Nordenskjöld, A., von Knorring, L., & Engström, I. (2011). Predictors of time to relapse/recurrence after electroconvulsive therapy in patients with major depressive disorder: A population-based cohort study. Depression Research and Treatment, 2011, 470985. https://doi.org/10.1155/2011/470985

Patel, S. R., Aronson, J. P., Sheth, S. A., & Eskandar, E. N. (2013). Lesion procedures in psychiatric neurosurgery. World Neurosurgery, 80(3–4 Suppl.), S3.e9–S3.e16. https://doi.org/10.1016/j.wneu.2012.11.038

Dashti, S. R., Baharvahdat, H., Spetzler, R. F., et al. (2008). Operative intracranial infection following craniotomy. Neurosurgical Focus, 24(6), E10. https://doi.org/10.3171/FOC/2008/24/6/E10

Ochsner, K. N., Kosslyn, S. M., Cosgrove, G. R., et al. (2001). Deficits in visual cognition and attention following bilateral anterior cingulotomy. Neuropsychologia, 39(3), 219–230. https://doi.org/10.1016/S0028-3932(00)00114-7

Rossi, S., Hallett, M., Rossini, P. M., & Pascual-Leone, A. (2009). Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clinical Neurophysiology, 120(12), 2008–2039. https://doi.org/10.1016/j.clinph.2009.08.016

Medical devices; neurological devices; classification of repetitive transcranial magnetic stimulation system. Final rule. (2011). Federal Register, 76(145), 44489–44491.

Xie, J., Chen, J., & Wei, Q. (2013). Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: A meta-analysis of stimulus parameter effects. Neurological Research, 35(10), 1084–1091. https://doi.org/10.1179/1743132813Y.0000000245


Article metrics
View details
1
Downloads
0
Citations
11
Views
📖 Cite article

View Dimensions


View Plumx


View Altmetric



1
Save
0
Citation
11
View
0
Share